Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Surg Res. 2019 Aug 13;245:153–162. doi: 10.1016/j.jss.2019.07.021

Figure 4: Comparison of MR score among unaffected, affected, and malignant samples.

Figure 4:

Abbreviations: unaffected = patients that do not develop breast cancer after initial benign biopsy; affected = patients that developed breast cancer after initial benign biopsy during follow up; malignant = patients diagnosed with breast cancer on initial biopsy; MR = malignancy risk.